Published in Ann Intern Med on April 01, 1972
The diagnosis of art: scleroderma in Paul Klee – and Rembrandt’s scholar? J R Soc Med (2010) 0.75
Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum (1980) 3.87
Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma). Arthritis Rheum (1968) 2.30
Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum (1984) 2.17
Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum (1980) 2.13
Eosinophilic fasciitis. A pathologic study of twenty cases. Am J Pathol (1979) 2.02
Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med (1971) 2.00
D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis. Ann Intern Med (1982) 1.84
Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum (1986) 1.72
Giant synovial cysts of the calf in patients with rheumatoid arthritis. J Bone Joint Surg Am (1968) 1.62
Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med (1977) 1.57
Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum (1979) 1.57
Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma). J Clin Invest (1976) 1.55
Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma). J Lab Clin Med (1978) 1.47
A brief history of the rheumatic diseases. Bull Rheum Dis (1982) 1.46
The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis. Ann Intern Med (1967) 1.45
Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Medicine (Baltimore) (1983) 1.44
Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthritis Rheum (1985) 1.42
Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. Medicine (Baltimore) (1980) 1.39
Effect of food, fast and alcohol on serum uric acid and acute attacks of gout. Am J Med (1967) 1.38
Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum (1984) 1.35
Letter: HL-A antigens in progressive systemic sclerosis (scleroderma). Arthritis Rheum (1975) 1.33
Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese literature. Arthritis Rheum (1984) 1.30
The rheumatic manifestaions of progressive systemic sclerosis (scleroderma). Clin Orthop Relat Res (1968) 1.30
Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med (1984) 1.26
Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med (1984) 1.26
Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum (1985) 1.21
Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma). J Lab Clin Med (1981) 1.21
IMPAIRMENT OF URIC ACID EXCRETION IN GOUT. J Clin Invest (1962) 1.18
The early history of antirheumatic drugs. Arthritis Rheum (1970) 1.17
Skeletal muscle involvement in progressive systemic sclerosis (scleroderma). Arthritis Rheum (1968) 1.17
Anemia and scleroderma: frequency, causes, and marrow findings. Arch Intern Med (1968) 1.17
The ultrastructure of skin in progressive systemic sclerosis (scleroderma). I. Dermal collagen fibers. Am J Pathol (1971) 1.13
Serum anti-gamma-globulin and antinuclear factors in the aged. JAMA (1967) 1.13
The early history of synovia (joint fluid). Ann Intern Med (1966) 1.11
Collagen types synthesized in dermal fibroblast cultures from patients with early progressive systemic sclerosis. Arthritis Rheum (1980) 1.11
Chromosome abnormalities from cyclophosphamide therapy in rheumatoid arthritis and progressive systemic sclerosis (scleroderma). Arthritis Rheum (1974) 1.07
Allopurinol and gouty hyperuricemia. Efficacy of a single daily dose. JAMA (1975) 1.06
Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma. Chest (1983) 1.03
Sjögren's syndrome in progressive systemic sclerosis. Ann Intern Med (1977) 1.02
Cellular immunity in progressive systemic sclerosis (scleroderma). Ann Rheum Dis (1972) 0.99
Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med (1986) 0.99
Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism. Ann Intern Med (1981) 0.98
Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycan. J Lab Clin Med (1983) 0.98
Soluble mediators from mononuclear cells increase the synthesis of glycosaminoglycan by dermal fibroblast cultures derived from normal subjects and progressive systemic sclerosis patients. Arthritis Rheum (1985) 0.98
Clinical and serologic study of Sjögren's syndrome in patients with progressive systemic sclerosis. Arthritis Rheum (1983) 0.97
Bleomycin-induced scleroderma. J Rheumatol (1981) 0.96
Histocompatibility antigens in progressive systemic sclerosis (scleroderma). J Rheumatol (1977) 0.96
Hippocrates, Galen, and synovia. Ann Intern Med (1972) 0.95
Ultrastructural studies in hypertension. II. Renal vascular changes in progressive systemic sclerosis. Lab Invest (1966) 0.93
Proceedings: Eosinophilic fasciitis. Report of six cases of a newly recognized scleroderma-like syndrome. Arthritis Rheum (1976) 0.93
Suppressor cell function and T lymphocyte subpopulations in peripheral blood of patients with progressive systemic sclerosis. Arthritis Rheum (1983) 0.92
Immune complexes in progressive systemic sclerosis (scleroderma). Arthritis Rheum (1982) 0.91
The effect of D-penicillamine on pulmonary findings in systemic sclerosis. Arthritis Rheum (1985) 0.91
Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma). J Clin Immunol (1982) 0.90
Anaerobic glycolysis and lactate dehydrogenase (LDH) isoenzymes in articular cartilage. J Lab Clin Med (1969) 0.90
HLA-DR antigens in progressive systemic sclerosis (scleroderma). J Rheumatol (1983) 0.89
Persistence of scleroderma-like phenotype in normal fibroblasts after prolonged exposure to soluble mediators from mononuclear cells. Arthritis Rheum (1986) 0.87
Products of activated mononuclear cells modulate accumulation of collagen by normal dermal and scleroderma fibroblasts in culture. J Lab Clin Med (1984) 0.87
Collagen accumulation by dermal fibroblast cultures of patients with linear localized scleroderma. J Rheumatol (1980) 0.87
Treatment of the gout and other forms of crystal-induced arthritis. Bull Rheum Dis (1982) 0.86
Alpha-1-antitrypsin in progressive systemic sclerosis. Arthritis Rheum (1980) 0.85
Immunopathology of the renal vascular lesion of progressive systemic sclerosis (scleroderma). Am J Pathol (1978) 0.85
Chromosomal abnormalities in progressive systemic sclerosis (scleroderma) with consideration of radiation effects. J Lab Clin Med (1975) 0.85
Resorption of the mandibular condyles and coronoid processes in progressive systemic sclerosis (scleroderma). Arthritis Rheum (1981) 0.84
Reduced T lymphoid colony growth in patients with progressive systemic sclerosis and rheumatoid arthritis. J Lab Clin Med (1982) 0.83
When is scleroderma not scleroderma? The differential diagnosis of progressive systemic sclerosis. Bull Rheum Dis (1981) 0.82
Capillary microscopy in eosinophilic fasciitis. A comparison with systemic sclerosis. Arthritis Rheum (1983) 0.82
Serum amyloid A protein concentration in progressive systemic sclerosis (scleroderma). Ann Rheum Dis (1984) 0.82
Serum eosinophilotactic activity in eosinophilic fasciitis. Arthritis Rheum (1982) 0.82
HLA-D antigens in progressive systemic sclerosis (scleroderma). Immunol Commun (1981) 0.81
Conjugal progressive systemic sclerosis (scleroderma): report of the disease in husband and wife. Arthritis Rheum (1984) 0.80
Proceedings: HL-A antigen 27 and psoriatic spondylitis. Arthritis Rheum (1974) 0.80
Studies of endogenous catecholamines in patients with Raynaud's phenomenon secondary to progressive systemic sclerosis (scleroderma). Am J Med (1972) 0.80
Relapsing polychondritis. Radiology (1973) 0.80
The early history and nomenclature of scleroderma and of its differentiation from sclerema neonatorum and scleroedema. Semin Arthritis Rheum (1982) 0.79
Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. Exercise radionuclide evaluation and comparison with diffuse scleroderma. Am J Med (1984) 0.79
Stimulation of lymphocyte reactivity by a low molecular weight cutaneous antigen in patients with progressive systemic sclerosis (scleroderma). J Rheumatol (1979) 0.78
Circulating immune complexes in eosinophilic fasciitis. Arthritis Rheum (1982) 0.76
Prostaglandin-mediated inhibition of lymphokine secretion in normal individuals and patients with progressive systemic sclerosis (scleroderma, PSS). Agents Actions (1982) 0.76
Progressive systemic sclerosis and penicillamine. J Rheumatol Suppl (1981) 0.76
St. Wolfgang and gout. Br Med J (1968) 0.75
Synovial fluid in antiquity. Ann Rheum Dis (1981) 0.75
Surface proteins of scleroderma fibroblasts in culture. J Rheumatol (1984) 0.75
Olecranon bursitis and bacteremia due to Serratia marcescens. J Rheumatol (1984) 0.75
Efficacy of single daily dose allopurinol in gouty hyperuricemia. Adv Exp Med Biol (1974) 0.75
Gout and the spider. JAMA (1970) 0.75
ECS elaborated. N Engl J Med (1972) 0.75
HLA-A and B antigens in eosinophilic fasciitis. J Rheumatol (1981) 0.75
Arthritis associated with hematologic disorders. Bull Rheum Dis (1965) 0.75
Invitation to the gout. A consideration of the role of various predisposing and provocative factors in the genesis of acute gouty arthritis. Trans Stud Coll Physicians Phila (1967) 0.75
The mystery of the missing tennant: a note on the early analysis of gouty tophi. J Hist Med Allied Sci (1974) 0.75
Growth and development of rheumatology in the United States--a bicentennial report. Presidential address to the American Rheumatism Association. Arthritis Rheum (1977) 0.75
Wrist drop in progressive systemic sclerosis (scleroderma): complete rupture of the extensor tendon mechanism. Arthritis Rheum (1985) 0.75
Who's Who. Science (1969) 0.75
Gout and other crystalline forms of arthritis. Postgrad Med (1975) 0.75
Response of patients with renal involvement by progressive systemic sclerosis to antihypertensive therapy. Clin Sci (Lond) (1981) 0.75
Dr. J. Claude Bennett to assume editorship. Arthritis Rheum (1976) 0.75
Prevention of hyperuricemia by allopurinol in hypertensive patients treated with chlorothiazide. N Engl J Med (1970) 0.75
D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects. J Rheumatol (1983) 0.75
Simultaneous measurement of plasma and erythrocyte oxypurines. II. Gouty patients with and without allopurinol medication. Gynecol Invest (1972) 0.75